Algernon Pharmaceuticals Announces 154 Patients Enrolled in its Multinational Phase 2b/3 Human Study of Ifenprodil for COVID-19
Stock Information for Algernon Pharmaceuticals Inc.
Loading
Please wait while we load your information from QuoteMedia.